
Aktiviere Job-Benachrichtigungen per E-Mail!
Erstelle in nur wenigen Minuten einen maßgeschneiderten Lebenslauf
Überzeuge Recruiter und verdiene mehr Geld. Mehr erfahren
A leading university hospital in Germany is seeking a researcher to work on antibiotic drug discovery for Mycobacterium tuberculosis. This role involves developing automated screening pipelines and collaborating with bioinformatics teams. Candidates must possess a PhD in Microbiology or a related field, with skills in high-throughput screening and automation. The position offers flexible work options and the potential for career growth within a supportive team environment.
We are one of the leading university hospitals in Germany and network research, teaching and health care at the highest level. That's why many things are a lot bigger for us: the spectrum of exciting development opportunities. The limitless openness with which specialists from all over the world work together here. Or our commitment as an employer to support all employees as best we can in reconciling their job with their goals and life situations.
This is the University Hospital of Cologne: Everything but ordinary.
The Translational Research Unit - Infectious Diseases (TRU-ID) within the Division for Clinical Infectious Diseases (Department I of Internal Medicine) conducts research aimed at improving our immunological understanding of infectious diseases. Our ultimate goal is to develop innovative therapies for serious bacterial infections like tuberculosis. With the support of our close network of partners at the University of Cologne, as well as our national and international collaborators, we are working to advance these innovative therapeutic concepts toward clinical application. Our studies are funded by the German Centre for Infection Research (DZIF), the Federal Ministry of Education and Research (BMBF), the German Research Foundation (DFG) and the European Union, among others.
As part of the DFG’s Collaborative Research Centre 1310 (Predictability in Evolution), your project will focus on implementing robotics-based, high-throughput screening workflows and integrating multi-omics data to study the evolutionary dynamics of Mtb antibiotic resistance. You will therefore take advantage of state-of-the-art equipment (e.g. a Beckman Echo/Access liquid handler workstation and an Agilent Cytation 10 confocal plate imager/reader) in BSL2 and BSL3 laboratories located at the Center for Molecular Medicine Cologne (CMMC) and the Translational Research in Oncology and Infectious Diseases (TRIO) building.
Applications from female candidates are expressly welcome and will be given priority in the event of equal suitability, competence and professional performance. People with disabilities are welcome to apply and will be treated preferentially in the event of equal suitability and qualification. The position is suitable for staffing with part-time employees.